KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Receivables (2018 - 2025)

Progyny (PGNY) has disclosed Receivables for 8 consecutive years, with $254.2 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 9.97% to $254.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $254.2 million through Dec 2025, down 9.97% year-over-year, with the annual reading at $254.2 million for FY2025, 9.97% down from the prior year.
  • Receivables for Q4 2025 was $254.2 million at Progyny, down from $296.8 million in the prior quarter.
  • The five-year high for Receivables was $370.3 million in Q2 2024, with the low at $139.9 million in Q1 2021.
  • Average Receivables over 5 years is $279.5 million, with a median of $291.9 million recorded in 2023.
  • The sharpest move saw Receivables surged 102.36% in 2022, then fell 13.3% in 2025.
  • Over 5 years, Receivables stood at $158.3 million in 2021, then surged by 78.8% to $283.0 million in 2022, then rose by 1.41% to $287.0 million in 2023, then dropped by 1.62% to $282.3 million in 2024, then fell by 9.97% to $254.2 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $254.2 million, $296.8 million, and $321.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.